Editorial: Epigenetic and genetic mechanisms underlying cardiovascular diseases and neurodevelopmental disorders
Open Access
- 3 April 2024
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 15, 1401354
Abstract
Epigenetic and genetic mechanisms underlying cardiovascular diseases and neurodevelopmental disorders Cardiovascular diseases (CVD) and neurodevelopmental disorders (NDD) represent significant health challenges, posing severe threats to human health and quality of life. Emerging as the foremost cause of mortality and disability globally, CVD is intricately linked with a variety of factors such as chronic inflammation and genetic predispositions (Dzau and Hodgkinson, 2024). Similarly, NDD, characterized by deficits in cognitive functions, social interactions, and learning capabilities (Olson et al., 2024), demands deeper understanding of their genetic and epigenetic underpinnings. The complexities of these diseases stem from a multifaceted etiology involving DNA variants, epigenetic modifications, and environmental influences, a narrative supported by research from Srour and Shevell (2014), Homberg et al. (2016), and Hartiala et al. (2021). Chronic inflammation plays a pivotal role in CVD, such as acute myocardial infarction (AMI) and coronary artery disease (CAD) (Liu C. et al., 2022; Lopez-Candales et al., 2017). Macrophage migration inhibitory factor (MIF) is an important pro-inflammatory cytokine implicated in the pathogenesis of CVD (Zernecke et al., 2008). MIF gene, located at 22q11.2, features polymorphisms such as-173 G/C polymorphism (rs755622), and-974 CATT tetranucleotide repeat (rs5844572), which may influence gene transcription and inflammatory processes. Fouda et al. conducted a meta-analysis of the MIF-173G/C variant's impact on CVD risk in 9,047 participants, revealing its association with increased CVD risk in specific populations, highlighting the genetic underpinnings of inflammation in CVD. AMI is a life-threatening disease involving thrombosis, fibrinolysis, inflammation, and lipid metabolism. Jeon et al. identified six early-onset AMI-associated variants, notably rs12639023 as a prognostic marker for cardiac mortality. This genetic perspective is crucial for understanding AMI's complex pathogenesis. Despite extensive research, theKeywords
This publication has 18 references indexed in Scilit:
- Differential Diagnosis of Autism and Other Neurodevelopmental DisordersPediatric Clinics of North America, 2024
- The gut microbiome and microbial metabolites in acute myocardial infarctionJournal of Genetics and Genomics, 2022
- Gene-Environment Interactions for Cardiovascular DiseaseCurrent Atherosclerosis Reports, 2021
- PRRT2 Related Epilepsies: A Gene ReviewJournal of Pediatric Neurology, 2021
- Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?Cardiovascular Research, 2021
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEuropean Heart Journal, 2019
- Sick Sinus SyndromeCardiac Electrophysiology Clinics, 2018
- Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to bedsBrain Research Bulletin, 2016
- Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertensionExperimental & Molecular Medicine, 2015
- Benign familial infantile seizuresBrain and Development, 2005